It is an IT services and IT enabled services provider that provides solutions for Business Transformation, Information Management, Application Development & Testing. The company is listed on the NSE and BSE Stock Exchanges. Augmento Labs, that will be merged into Saksoft, is a digital engineering firm catering to enterprise customers.
The shares of Saksoft are currently at Rs. 143 . 65, down by 2.94%. The company has a market capitalization of Rs. 1,905.56 crore. The stock’s 52 week high is Rs. 222.99 and its 52 week low is Rs. 107.59. In the past 6 months the stock has delivered a return of 22.35%.
What’s The News
Order in regard to Scheme of Amalgamation between Augmento Labs Private Limited and Saksoft Limited is made by the National Company Law Tribunal, Chennai Bench with judicial member Sanjiv Jain and technical member Venkataraman Subramaniam under sections 230 to 232 of the Companies Act, 2013.
The appointed date of the Scheme is 1st April 2026. But the Scheme will only become effective after the submission of the certified copy of the order of the NCLT to the Registrar of Companies, Chennai. This implies that the sanctioning of the NCLT cannot be considered as the date of effectiveness of the merger.
Key Details of the Merger
In accordance with the proposed combination, Augmento Labs will be absorbed into its parent company, Saksoft. In light of the fact that Augmento Labs is a wholly owned subsidiary, it would mean that there will be no issue of new shares to the shareholders of Augmento Labs through the combination scheme. The shares of Augmento Labs owned by Saksoft will be canceled through the combination scheme.
The combination is intended to simplify the group’s business structure by removing one of the entities. Through the combination, it would be possible to reduce duplication in management and administration.
Acquisition Background
Saksoft has acquired Augmento Labs through a Share Purchase Agreement dated June 12, 2024. From the merger announcement disclosures, the aggregate consideration in connection with the acquisition, including deferred earn-out consideration, has been found to be Rs. 97.50 crore, and such consideration had been fully paid prior to the approval of the amalgamation by NCLT.
Therefore, the current transaction is primarily a post-acquisition corporate consolidation, rather than a new acquisition requiring an additional Rs. 97.50 crore cash outflow.
Rationale Behind the Merger
According to the scheme documents, the amalgamation is intended to consolidate the businesses of Saksoft and Augmento Labs under a single corporate structure. The company has cited potential benefits including economies of scale, operational rationalisation, organisational efficiency, better cash-flow management and improved utilisation of resources.
The consolidation is also expected to eliminate inter-company dependencies and duplication of activities. Bringing the wholly owned subsidiary directly into Saksoft could reduce the administrative and regulatory burden associated with maintaining a separate legal entity.
Regulatory Proceedings
The merger process involved proceedings before the NCLT Chennai Bench. Earlier, the Tribunal had considered the first-motion application and subsequently directed the companies to issue notices to the relevant statutory and regulatory authorities.
The Regional Director, Registrar of Companies, Income Tax Department and Official Liquidator had raised observations relating to aspects including the appointed date, employee protection and accounting treatment. Saksoft and Augmento Labs submitted responses and undertakings addressing these observations. The Official Liquidator’s report also stated that there was no instance of misfeasance or diversion of funds identified in the affairs of Augmento Labs.
Impact on Saksoft
The merger will bring Augmento Labs’ business, assets and liabilities directly under Saksoft. As the subsidiary is already consolidated in Saksoft’s financial statements, the transaction is primarily a legal and organisational consolidation and should not by itself represent the addition of an entirely new business to the consolidated financial statements. Saksoft had previously disclosed that Augmento Labs was included in its consolidated financial results.
The key potential benefits highlighted in the scheme relate to simplification of the group structure, reduction in duplicated costs and compliance requirements, and more efficient deployment of cash flows and resources. The actual financial impact will depend on the operating performance of the combined businesses following completion of the merger.
Investor Perspective
For investors, the NCLT approval marks an important procedural milestone in Saksoft’s plan to consolidate Augmento Labs into the parent company. Since Augmento Labs is a wholly owned subsidiary and its financials are already consolidated with Saksoft, the transaction is principally a corporate restructuring exercise rather than a fresh business acquisition.
The next important step is completion of the required statutory filings so that the scheme becomes effective. Investors can subsequently track whether the simplified structure translates into lower administrative costs, improved operational efficiency and better utilisation of resources across the combined business.